3.8 Article

Implementation and evaluation of axillary reverse mapping technique in breast cancer patients using patent blue dye

Related references

Note: Only part of the references are listed.
Review Oncology

Axillary reverse mapping (ARM): where to go

Xuan Shao et al.

BREAST CANCER (2019)

Review Surgery

Systematic review of axillary reverse mapping in breast cancer

M. Ahmed et al.

BRITISH JOURNAL OF SURGERY (2016)

Article Oncology

Axillary Reverse Mapping in Patients With Breast Cancer: Is it Oncologically Safe?

Nicholas K. Ngui et al.

JOURNAL OF SURGICAL ONCOLOGY (2016)

Editorial Material Oncology

Z-11 trial and rethinking axillary reverse mapping

Masakuni Noguchi

BREAST CANCER (2015)

Article Surgery

Axillary reverse mapping: Five-year experience

Daniela Ochoa et al.

SURGERY (2014)

Article Surgery

Management of the Axilla

Barbara Zarebczan Dull et al.

SURGICAL CLINICS OF NORTH AMERICA (2013)

Article Medicine, General & Internal

Association of Occult Metastases in Sentinel Lymph Nodes and Bone Marrow With Survival Among Women With Early-Stage Invasive Breast Cancer

Armando E. Giuliano et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)

Article Oncology

Extensive Nodal Disease May Impair Axillary Reverse Mapping in Patients With Breast Cancer

Riccardo Ponzone et al.

JOURNAL OF CLINICAL ONCOLOGY (2009)

Article Oncology

Axillary reverse mapping (ARM): A new concept to identify and enhance lymphatic preservation

Margaret Thompson et al.

ANNALS OF SURGICAL ONCOLOGY (2007)

Article Surgery

A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping

WD Blessing et al.

AMERICAN JOURNAL OF SURGERY (2002)